Organovo Current Deferred Revenue vs Capital Stock Analysis

ONVO Stock

USD 1.07 0.03 2.88%

Organovo Holdings financial indicator trend analysis is much more than just breaking down Organovo Holdings prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Organovo Holdings is a good investment. Please check the relationship between Organovo Holdings Current Deferred Revenue and its Capital Stock accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organovo Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Organovo Stock, please use our How to Invest in Organovo Holdings guide.

Current Deferred Revenue vs Capital Stock

Current Deferred Revenue vs Capital Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Organovo Holdings Current Deferred Revenue account and Capital Stock. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Organovo Holdings' Current Deferred Revenue and Capital Stock is 0.15. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Capital Stock in the same time period over historical financial statements of Organovo Holdings, assuming nothing else is changed. The correlation between historical values of Organovo Holdings' Current Deferred Revenue and Capital Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Organovo Holdings are associated (or correlated) with its Capital Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Stock has no effect on the direction of Current Deferred Revenue i.e., Organovo Holdings' Current Deferred Revenue and Capital Stock go up and down completely randomly.

Correlation Coefficient

0.15

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Capital Stock

The total amount of a company’s capital funded by shareholders through the issue and subscription of shares.

Most indicators from Organovo Holdings' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Organovo Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organovo Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Organovo Stock, please use our How to Invest in Organovo Holdings guide.As of the 1st of May 2024, Selling General Administrative is likely to grow to about 14.4 M, while Tax Provision is likely to drop 1,710.

	2021	2022	2023	2024 (projected)
Cost Of Revenue	142K	293K	263.7K	250.5K
Research Development	3.3M	8.9M	8.0M	7.6M

Cost Of Revenue Research Development

Organovo Holdings fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Long Term Debt Total	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Non Current Liabilities Total	Inventory	Property Plant And Equipment Gross	Other Current Liab	Property Plant And Equipment Net	Current Deferred Revenue	Other Assets
Total Assets		0.02	0.97	-0.95	-0.31	0.75	0.97	1.0	0.49	-0.03	0.81	0.41	0.04	1.0	0.61	0.3	0.58	0.0	0.42	0.15	0.24	0.43	-0.71	0.57	-0.36	-0.12
Total Current Liabilities	0.02		-0.22	-0.03	0.22	0.2	0.02	0.01	0.16	-0.39	0.04	-0.24	0.99	0.02	0.21	-0.33	0.0	-0.22	0.13	-0.18	0.28	-0.01	0.34	0.02	0.26	-0.3
Total Stockholder Equity	0.97	-0.22		-0.93	-0.33	0.68	0.94	0.97	0.46	0.04	0.77	0.44	-0.2	0.97	0.56	0.35	0.54	0.04	0.38	0.16	0.18	0.39	-0.76	0.53	-0.42	-0.06
Net Debt	-0.95	-0.03	-0.93		0.16	-0.71	-1.0	-0.96	-0.6	0.14	-0.72	-0.3	-0.04	-0.96	-0.7	-0.17	-0.44	0.08	-0.4	0.07	-0.31	-0.3	0.61	-0.45	0.35	0.24
Retained Earnings	-0.31	0.22	-0.33	0.16		-0.19	-0.21	-0.27	0.09	-0.85	-0.72	-0.96	0.16	-0.28	-0.06	-0.8	-0.55	-0.68	-0.07	-0.78	0.27	-0.55	0.8	-0.36	0.35	-0.74
Accounts Payable	0.75	0.2	0.68	-0.71	-0.19		0.72	0.75	0.53	-0.09	0.63	0.27	0.21	0.75	0.62	0.09	0.41	-0.21	0.33	0.08	0.1	0.35	-0.46	0.45	-0.32	-0.12
Cash	0.97	0.02	0.94	-1.0	-0.21	0.72		0.97	0.57	-0.08	0.76	0.35	0.04	0.97	0.67	0.2	0.49	-0.04	0.39	-0.01	0.28	0.35	-0.65	0.49	-0.37	-0.2
Cash And Short Term Investments	1.0	0.01	0.97	-0.96	-0.27	0.75	0.97		0.51	-0.07	0.79	0.37	0.03	1.0	0.62	0.26	0.52	-0.03	0.39	0.1	0.22	0.37	-0.7	0.52	-0.38	-0.13
Common Stock Total Equity	0.49	0.16	0.46	-0.6	0.09	0.53	0.57	0.51		-0.38	0.33	0.0	0.13	0.51	0.95	0.03	-0.08	-0.62	0.57	-0.32	0.56	-0.1	-0.18	0.04	-0.12	-0.41
Common Stock Shares Outstanding	-0.03	-0.39	0.04	0.14	-0.85	-0.09	-0.08	-0.07	-0.38		0.43	0.86	-0.31	-0.07	-0.28	0.68	0.53	0.76	-0.16	0.8	-0.43	0.61	-0.59	0.35	-0.24	0.74
Other Current Assets	0.81	0.04	0.77	-0.72	-0.72	0.63	0.76	0.79	0.33	0.43		0.8	0.08	0.79	0.5	0.5	0.65	0.35	0.37	0.42	0.05	0.56	-0.88	0.53	-0.54	0.25
Other Stockholder Equity	0.41	-0.24	0.44	-0.3	-0.96	0.27	0.35	0.37	0.0	0.86	0.8		-0.17	0.38	0.15	0.78	0.63	0.66	0.11	0.72	-0.22	0.63	-0.85	0.45	-0.39	0.65
Total Liab	0.04	0.99	-0.2	-0.04	0.16	0.21	0.04	0.03	0.13	-0.31	0.08	-0.17		0.04	0.2	-0.27	0.09	-0.17	0.14	-0.09	0.28	0.09	0.3	0.1	0.26	-0.27
Total Current Assets	1.0	0.02	0.97	-0.96	-0.28	0.75	0.97	1.0	0.51	-0.07	0.79	0.38	0.04		0.63	0.27	0.53	-0.03	0.41	0.11	0.24	0.38	-0.7	0.53	-0.37	-0.14
Common Stock	0.61	0.21	0.56	-0.7	-0.06	0.62	0.67	0.62	0.95	-0.28	0.5	0.15	0.2	0.63		0.11	0.03	-0.52	0.57	-0.21	0.51	0.0	-0.33	0.12	-0.22	-0.33
Short Long Term Debt Total	0.3	-0.33	0.35	-0.17	-0.8	0.09	0.2	0.26	0.03	0.68	0.5	0.78	-0.27	0.27	0.11		0.55	0.47	0.29	0.73	0.08	0.51	-0.59	0.46	0.12	0.55
Non Current Assets Total	0.58	0.0	0.54	-0.44	-0.55	0.41	0.49	0.52	-0.08	0.53	0.65	0.63	0.09	0.53	0.03	0.55		0.42	0.34	0.7	0.14	0.96	-0.57	0.96	-0.05	0.08
Non Currrent Assets Other	0.0	-0.22	0.04	0.08	-0.68	-0.21	-0.04	-0.03	-0.62	0.76	0.35	0.66	-0.17	-0.03	-0.52	0.47	0.42		-0.34	0.53	-0.46	0.36	-0.44	0.16	-0.2	0.72
Net Receivables	0.42	0.13	0.38	-0.4	-0.07	0.33	0.39	0.39	0.57	-0.16	0.37	0.11	0.14	0.41	0.57	0.29	0.34	-0.34		-0.03	0.88	0.27	-0.08	0.45	0.08	-0.46
Non Current Liabilities Total	0.15	-0.18	0.16	0.07	-0.78	0.08	-0.01	0.1	-0.32	0.8	0.42	0.72	-0.09	0.11	-0.21	0.73	0.7	0.53	-0.03		-0.29	0.77	-0.54	0.61	-0.03	0.59
Inventory	0.24	0.28	0.18	-0.31	0.27	0.1	0.28	0.22	0.56	-0.43	0.05	-0.22	0.28	0.24	0.51	0.08	0.14	-0.46	0.88	-0.29		0.05	0.25	0.28	0.36	-0.67
Property Plant And Equipment Gross	0.43	-0.01	0.39	-0.3	-0.55	0.35	0.35	0.37	-0.1	0.61	0.56	0.63	0.09	0.38	0.0	0.51	0.96	0.36	0.27	0.77	0.05		-0.52	0.94	-0.05	0.11
Other Current Liab	-0.71	0.34	-0.76	0.61	0.8	-0.46	-0.65	-0.7	-0.18	-0.59	-0.88	-0.85	0.3	-0.7	-0.33	-0.59	-0.57	-0.44	-0.08	-0.54	0.25	-0.52		-0.43	0.59	-0.46
Property Plant And Equipment Net	0.57	0.02	0.53	-0.45	-0.36	0.45	0.49	0.52	0.04	0.35	0.53	0.45	0.1	0.53	0.12	0.46	0.96	0.16	0.45	0.61	0.28	0.94	-0.43		0.06	-0.14
Current Deferred Revenue	-0.36	0.26	-0.42	0.35	0.35	-0.32	-0.37	-0.38	-0.12	-0.24	-0.54	-0.39	0.26	-0.37	-0.22	0.12	-0.05	-0.2	0.08	-0.03	0.36	-0.05	0.59	0.06		-0.2
Other Assets	-0.12	-0.3	-0.06	0.24	-0.74	-0.12	-0.2	-0.13	-0.41	0.74	0.25	0.65	-0.27	-0.14	-0.33	0.55	0.08	0.72	-0.46	0.59	-0.67	0.11	-0.46	-0.14	-0.2

Click cells to compare fundamentals

Organovo Holdings Account Relationship Matchups

Organovo Holdings fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	28.4M	39.9M	33.3M	20.3M	23.4M	39.7M
Total Current Liabilities	1.8M	721K	1.4M	3.7M	3.3M	3.4M
Total Stockholder Equity	26.6M	39.2M	30.2M	15.3M	17.6M	34.6M
Net Debt	(27.4M)	(37.4M)	(26.5M)	(13.5M)	(12.1M)	(12.8M)
Retained Earnings	(279.5M)	(296.3M)	(307.7M)	(325.0M)	(292.5M)	(277.9M)
Accounts Payable	720K	281K	415K	331K	380.7K	588.6K
Cash	27.4M	37.4M	28.7M	15.3M	17.6M	16.7M
Cash And Short Term Investments	27.4M	37.4M	28.7M	16.0M	18.4M	36.2M
Common Stock Total Equity	111K	124K	131K	9K	10.4K	9.8K
Common Stock Shares Outstanding	6.5M	6.9M	8.7M	8.7M	10.0M	5.8M
Liabilities And Stockholders Equity	28.4M	39.9M	33.3M	20.3M	23.4M	39.7M
Other Current Assets	851K	1.0M	858K	889K	1.0M	882.9K
Other Stockholder Equity	306.0M	335.5M	337.9M	340.3M	391.4M	231.8M
Total Liab	1.8M	721K	3.1M	5.0M	4.5M	3.8M
Total Current Assets	28.3M	38.4M	29.5M	17.0M	19.6M	37.5M
Common Stock	111K	124K	131K	9K	10.4K	9.8K
Non Current Assets Total	123K	1.5M	3.8M	3.3M	3.8M	2.4M
Non Currrent Assets Other	123K	1.1M	948K	658K	756.7K	407.6K
Net Receivables	558K	111K	0.0	152K	136.8K	226.8K
Non Current Liabilities Total	720K	281K	1.7M	1.3M	1.5M	1.6M
Property Plant And Equipment Gross	415K	381K	3.9M	3.9M	4.5M	2.3M
Other Current Liab	1.1M	440K	489K	2.8M	2.6M	2.9M
Property Plant And Equipment Net	0.0	381K	2.8M	2.6M	3.0M	2.2M
Accumulated Other Comprehensive Income	(4.6M)	(415K)	0.0	2K	2.3K	2.4K
Intangible Assets	123K	109K	94K	13K	11.7K	11.1K
Net Tangible Assets	26.6M	39.1M	30.1M	15.3M	13.8M	13.1M
Net Invested Capital	26.6M	39.2M	30.2M	15.3M	13.8M	25.6M
Net Working Capital	26.5M	37.7M	28.2M	13.4M	12.0M	11.4M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Organovo Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organovo Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organovo Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organovo Holdings Stock:

How To Invest In Organovo

Details

Is Organovo Stock a good investment?

Details

What is Organovo Holdings' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organovo Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Organovo Stock, please use our How to Invest in Organovo Holdings guide.

You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Organovo Stock analysis

When running Organovo Holdings' price analysis, check to measure Organovo Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organovo Holdings is operating at the current time. Most of Organovo Holdings' value examination focuses on studying past and present price action to predict the probability of Organovo Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organovo Holdings' price. Additionally, you may evaluate how the addition of Organovo Holdings to your portfolios can decrease your overall portfolio volatility.

	Bonds Directory Find actively traded corporate debentures issued by US companies
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance

Is Organovo Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organovo Holdings. If investors know Organovo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organovo Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.16)

Revenue Per Share

0.027

Quarterly Revenue Growth

(0.96)

Return On Assets

(0.73)

Return On Equity

(1.34)

The market value of Organovo Holdings is measured differently than its book value, which is the value of Organovo that is recorded on the company's balance sheet. Investors also form their own opinion of Organovo Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organovo Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organovo Holdings' market value can be influenced by many factors that don't directly affect Organovo Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Organovo Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organovo Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organovo Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Organovo Current Deferred Revenue vs Capital Stock Analysis

Current Deferred Revenue vs Capital Stock

Current Deferred Revenue vs Capital Stock Correlation Analysis

Correlation Coefficient

Current Deferred Revenue

Capital Stock

Organovo Holdings fundamental ratios Correlations

Organovo Holdings Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Organovo Holdings fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Organovo Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Liab	+ 0.99	Total Current Liabilities
Total Stockholder Equity	+ 0.97	Total Assets
Cash	+ 0.97	Total Assets

Cash	- 1.0	Net Debt
Other Stockholder Equity	- 0.96	Retained Earnings
Total Current Assets	- 0.96	Net Debt
Cash And Short Term Investments	- 0.96	Net Debt
Net Debt	- 0.95	Total Assets
Net Debt	- 0.93	Total Stockholder Equity